GLP-1
Glucagon-like peptide-1, an incretin hormone released in the gut after eating. It is the target of the drugs that have transformed the treatment of obesity.
Content reviewed by Dr. David Céspedes
Medical guides
Mounjaro before and after: what to expect month by month, according to the trials
ReadInsulin resistance: symptoms, how it is diagnosed and how to reverse it
ReadMounjaro reviews: what the trials show and what patients report
ReadHigh triglycerides: why they rise and how to really bring them down
ReadRybelsus price in Spain: cost per dose (3, 7 and 14 mg) and per month
ReadOzempic price in Spain: how much it costs per pen and per month in 2026
ReadVitamin D: what the evidence does (and doesn't) say about supplementing
ReadHow much does Mounjaro cost per month in Spain: the real price per dose in 2026
ReadOrforglipron (Foundayo), approved by the FDA: the first GLP-1 pill that can be taken without food or water restrictions
ReadAshwagandha: what it is, what the evidence says and why several European countries have restricted it
ReadSurvodutide: what it is and where it currently stands
ReadWeight regain after stopping treatment: why it happens and how it is managed
ReadMetabolic fatty liver disease: what it is, why it happens and what can be done
ReadOrforglipron (Foundayo): the first GLP-1 pill with no restrictions, and why it isn't available in Spain
ReadRetatrutide: what its phase 3 trial found, and why you can't get hold of it
ReadCagriSema: what it is, what the REDEFINE trials found and why it disappointed
ReadBuying Ozempic and Mounjaro in Spain: how to get them legally and safely
ReadOzempic and Mounjaro side effects: what to expect and how to manage them
ReadGLP-1: what it is, how it works and why it is transforming obesity treatment
ReadMounjaro vs Ozempic: clinical differences, effectiveness and which one suits you
ReadOzempic in Spain: what it is, how it works and who can take it
ReadHow much does a medical weight loss treatment cost in Spain: complete 2026 guide
Read
Keep reading
This entry is for information. Your case requires an individual medical assessment.